nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—PTGS1—esophageal cancer	0.883	1	CbGaD
Torasemide—CYP2C9—Capecitabine—esophageal cancer	0.0156	0.665	CbGbCtD
Torasemide—CYP2C9—Cisplatin—esophageal cancer	0.00788	0.335	CbGbCtD
Torasemide—Hyperuricaemia—Cisplatin—esophageal cancer	0.000547	0.0332	CcSEcCtD
Torasemide—Pain—Carboplatin—esophageal cancer	0.000528	0.0321	CcSEcCtD
Torasemide—Throat sore—Capecitabine—esophageal cancer	0.000519	0.0315	CcSEcCtD
Torasemide—Blood uric acid increased—Cisplatin—esophageal cancer	0.000517	0.0314	CcSEcCtD
Torasemide—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000515	0.0312	CcSEcCtD
Torasemide—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000414	0.0252	CcSEcCtD
Torasemide—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000412	0.025	CcSEcCtD
Torasemide—Hyponatraemia—Cisplatin—esophageal cancer	0.00037	0.0225	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000369	0.0224	CcSEcCtD
Torasemide—Dehydration—Cisplatin—esophageal cancer	0.000343	0.0208	CcSEcCtD
Torasemide—Hypokalaemia—Cisplatin—esophageal cancer	0.000335	0.0204	CcSEcCtD
Torasemide—Pancreatitis—Cisplatin—esophageal cancer	0.000312	0.019	CcSEcCtD
Torasemide—Hyperuricaemia—Methotrexate—esophageal cancer	0.0003	0.0182	CcSEcCtD
Torasemide—Atrial fibrillation—Capecitabine—esophageal cancer	0.000287	0.0174	CcSEcCtD
Torasemide—Thirst—Capecitabine—esophageal cancer	0.000285	0.0173	CcSEcCtD
Torasemide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000284	0.0172	CcSEcCtD
Torasemide—Arthritis—Capecitabine—esophageal cancer	0.00028	0.017	CcSEcCtD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000273	0.00354	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000273	0.00354	CbGpPWpGaD
Torasemide—Hyponatraemia—Capecitabine—esophageal cancer	0.000273	0.0166	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000272	0.0165	CcSEcCtD
Torasemide—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00027	0.0035	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000269	0.00349	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000266	0.00344	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—ADH7—esophageal cancer	0.000263	0.00341	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000262	0.00339	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000257	0.00333	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000256	0.00331	CbGpPWpGaD
Torasemide—Dehydration—Capecitabine—esophageal cancer	0.000253	0.0153	CcSEcCtD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000252	0.00327	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—ALDH2—esophageal cancer	0.000252	0.00327	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000249	0.00323	CbGpPWpGaD
Torasemide—Hypokalaemia—Capecitabine—esophageal cancer	0.000247	0.015	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000245	0.0149	CcSEcCtD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000244	0.00316	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00024	0.00311	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTT1—esophageal cancer	0.00024	0.00311	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000237	0.00307	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP2A6—esophageal cancer	0.000237	0.00307	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—ADH7—esophageal cancer	0.000235	0.00305	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000234	0.00304	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000233	0.00302	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000232	0.00301	CbGpPWpGaD
Torasemide—PTGS1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000231	0.003	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—ADH1B—esophageal cancer	0.000231	0.00299	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00023	0.00298	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000222	0.00288	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000219	0.00284	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000218	0.00283	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000216	0.0028	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP26A1—esophageal cancer	0.000215	0.00278	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.000214	0.00278	CbGpPWpGaD
Torasemide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000212	0.0129	CcSEcCtD
Torasemide—CYP2C8—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000212	0.00274	CbGpPWpGaD
Torasemide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000208	0.0126	CcSEcCtD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000207	0.00269	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—ADH1B—esophageal cancer	0.000206	0.00267	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTO1—esophageal cancer	0.0002	0.00259	CbGpPWpGaD
Torasemide—Leukopenia—Cisplatin—esophageal cancer	0.000199	0.0121	CcSEcCtD
Torasemide—CYP2C8—Metapathway biotransformation—GSTO1—esophageal cancer	0.000197	0.00255	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000195	0.00253	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000195	0.00252	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP26A1—esophageal cancer	0.000192	0.00248	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP1B1—esophageal cancer	0.000191	0.00247	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000189	0.00245	CbGpPWpGaD
Torasemide—Myalgia—Cisplatin—esophageal cancer	0.000189	0.0115	CcSEcCtD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000189	0.00245	CbGpPWpGaD
Torasemide—Haemoglobin—Capecitabine—esophageal cancer	0.000189	0.0115	CcSEcCtD
Torasemide—Rhinitis—Capecitabine—esophageal cancer	0.000188	0.0114	CcSEcCtD
Torasemide—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000188	0.00244	CbGpPWpGaD
Torasemide—Haemorrhage—Capecitabine—esophageal cancer	0.000188	0.0114	CcSEcCtD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000187	0.00242	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000184	0.00239	CbGpPWpGaD
Torasemide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000182	0.0111	CcSEcCtD
Torasemide—Oedema—Cisplatin—esophageal cancer	0.000181	0.011	CcSEcCtD
Torasemide—PTGS1—Biological oxidations—CYP19A1—esophageal cancer	0.00018	0.00233	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.000178	0.00231	CbGpPWpGaD
Torasemide—Erythema multiforme—Capecitabine—esophageal cancer	0.000178	0.0108	CcSEcCtD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000178	0.0023	CbGpPWpGaD
Torasemide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000177	0.0108	CcSEcCtD
Torasemide—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000176	0.00228	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000175	0.00226	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000172	0.00223	CbGpPWpGaD
Torasemide—Pancreatitis—Methotrexate—esophageal cancer	0.000171	0.0104	CcSEcCtD
Torasemide—Hypotension—Cisplatin—esophageal cancer	0.000169	0.0103	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000165	0.01	CcSEcCtD
Torasemide—CYP2C8—Biological oxidations—ALDH2—esophageal cancer	0.000163	0.00211	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000162	0.00211	CbGpPWpGaD
Torasemide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000161	0.00977	CcSEcCtD
Torasemide—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.00016	0.00208	CbGpPWpGaD
Torasemide—Pain—Cisplatin—esophageal cancer	0.000155	0.0094	CcSEcCtD
Torasemide—CYP2C8—Biological oxidations—GSTT1—esophageal cancer	0.000155	0.00201	CbGpPWpGaD
Torasemide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000155	0.00938	CcSEcCtD
Torasemide—CYP2C8—Biological oxidations—CYP2A6—esophageal cancer	0.000153	0.00198	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000149	0.00194	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000147	0.00191	CbGpPWpGaD
Torasemide—Syncope—Capecitabine—esophageal cancer	0.000147	0.00891	CcSEcCtD
Torasemide—Leukopenia—Capecitabine—esophageal cancer	0.000146	0.00889	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.000145	0.00188	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—PTGS1—esophageal cancer	0.000145	0.00188	CbGpPWpGaD
Torasemide—Loss of consciousness—Capecitabine—esophageal cancer	0.000144	0.00873	CcSEcCtD
Torasemide—Cough—Capecitabine—esophageal cancer	0.000143	0.00867	CcSEcCtD
Torasemide—Haemoglobin—Methotrexate—esophageal cancer	0.000141	0.00854	CcSEcCtD
Torasemide—Haemorrhage—Methotrexate—esophageal cancer	0.00014	0.00849	CcSEcCtD
Torasemide—Arthralgia—Capecitabine—esophageal cancer	0.000139	0.00846	CcSEcCtD
Torasemide—Chest pain—Capecitabine—esophageal cancer	0.000139	0.00846	CcSEcCtD
Torasemide—Myalgia—Capecitabine—esophageal cancer	0.000139	0.00846	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.000138	0.00179	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.000137	0.00177	CbGpPWpGaD
Torasemide—Oedema—Capecitabine—esophageal cancer	0.000134	0.00811	CcSEcCtD
Torasemide—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000133	0.00173	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000132	0.00172	CbGpPWpGaD
Torasemide—Erythema multiforme—Methotrexate—esophageal cancer	0.000132	0.00803	CcSEcCtD
Torasemide—Shock—Capecitabine—esophageal cancer	0.000131	0.00797	CcSEcCtD
Torasemide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000131	0.00794	CcSEcCtD
Torasemide—Asthenia—Cisplatin—esophageal cancer	0.00013	0.00789	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.000129	0.00168	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000126	0.00163	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000125	0.00162	CbGpPWpGaD
Torasemide—Hypotension—Capecitabine—esophageal cancer	0.000125	0.00757	CcSEcCtD
Torasemide—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000125	0.00161	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000124	0.00161	CbGpPWpGaD
Torasemide—Diarrhoea—Cisplatin—esophageal cancer	0.000124	0.00752	CcSEcCtD
Torasemide—CYP2C8—Biological oxidations—CYP1B1—esophageal cancer	0.000123	0.0016	CbGpPWpGaD
Torasemide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000122	0.00738	CcSEcCtD
Torasemide—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000122	0.00158	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000122	0.00158	CbGpPWpGaD
Torasemide—Insomnia—Capecitabine—esophageal cancer	0.000121	0.00733	CcSEcCtD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000119	0.00154	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000118	0.00153	CbGpPWpGaD
Torasemide—Dyspepsia—Capecitabine—esophageal cancer	0.000118	0.00713	CcSEcCtD
Torasemide—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	0.000116	0.0015	CbGpPWpGaD
Torasemide—Vomiting—Cisplatin—esophageal cancer	0.000115	0.00699	CcSEcCtD
Torasemide—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000114	0.00148	CbGpPWpGaD
Torasemide—Rash—Cisplatin—esophageal cancer	0.000114	0.00693	CcSEcCtD
Torasemide—Pain—Capecitabine—esophageal cancer	0.000114	0.00693	CcSEcCtD
Torasemide—Constipation—Capecitabine—esophageal cancer	0.000114	0.00693	CcSEcCtD
Torasemide—Dermatitis—Cisplatin—esophageal cancer	0.000114	0.00693	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.00011	0.00143	CbGpPWpGaD
Torasemide—Leukopenia—Methotrexate—esophageal cancer	0.000109	0.00662	CcSEcCtD
Torasemide—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000109	0.00141	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000109	0.00141	CbGpPWpGaD
Torasemide—Nausea—Cisplatin—esophageal cancer	0.000108	0.00653	CcSEcCtD
Torasemide—Cough—Methotrexate—esophageal cancer	0.000106	0.00645	CcSEcCtD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000106	0.00138	CbGpPWpGaD
Torasemide—Chest pain—Methotrexate—esophageal cancer	0.000104	0.00629	CcSEcCtD
Torasemide—Myalgia—Methotrexate—esophageal cancer	0.000104	0.00629	CcSEcCtD
Torasemide—Arthralgia—Methotrexate—esophageal cancer	0.000104	0.00629	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000104	0.00134	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000102	0.00132	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.0001	0.0013	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	9.9e-05	0.00128	CbGpPWpGaD
Torasemide—Thrombocytopenia—Methotrexate—esophageal cancer	9.73e-05	0.00591	CcSEcCtD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	9.68e-05	0.00125	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—BLVRB—esophageal cancer	9.65e-05	0.00125	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SLC52A3—esophageal cancer	9.65e-05	0.00125	CbGpPWpGaD
Torasemide—Asthenia—Capecitabine—esophageal cancer	9.58e-05	0.00582	CcSEcCtD
Torasemide—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	9.44e-05	0.00122	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	9.31e-05	0.00121	CbGpPWpGaD
Torasemide—Hypotension—Methotrexate—esophageal cancer	9.29e-05	0.00564	CcSEcCtD
Torasemide—Diarrhoea—Capecitabine—esophageal cancer	9.14e-05	0.00555	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.06e-05	0.0055	CcSEcCtD
Torasemide—Insomnia—Methotrexate—esophageal cancer	8.99e-05	0.00546	CcSEcCtD
Torasemide—Dizziness—Capecitabine—esophageal cancer	8.83e-05	0.00536	CcSEcCtD
Torasemide—Dyspepsia—Methotrexate—esophageal cancer	8.75e-05	0.00531	CcSEcCtD
Torasemide—Pain—Methotrexate—esophageal cancer	8.5e-05	0.00516	CcSEcCtD
Torasemide—Vomiting—Capecitabine—esophageal cancer	8.49e-05	0.00515	CcSEcCtD
Torasemide—Rash—Capecitabine—esophageal cancer	8.42e-05	0.00511	CcSEcCtD
Torasemide—Dermatitis—Capecitabine—esophageal cancer	8.41e-05	0.00511	CcSEcCtD
Torasemide—Headache—Capecitabine—esophageal cancer	8.37e-05	0.00508	CcSEcCtD
Torasemide—PTGS1—Metabolism—SLC10A2—esophageal cancer	8.2e-05	0.00106	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CA1—esophageal cancer	8.2e-05	0.00106	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.04e-05	0.00104	CbGpPWpGaD
Torasemide—Nausea—Capecitabine—esophageal cancer	7.93e-05	0.00481	CcSEcCtD
Torasemide—PTGS1—Metabolism—CA2—esophageal cancer	7.5e-05	0.000972	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.33e-05	0.00095	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.17e-05	0.00093	CbGpPWpGaD
Torasemide—Asthenia—Methotrexate—esophageal cancer	7.13e-05	0.00433	CcSEcCtD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.01e-05	0.000909	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ADH7—esophageal cancer	6.97e-05	0.000904	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PLCE1—esophageal cancer	6.97e-05	0.000904	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.89e-05	0.000893	CbGpPWpGaD
Torasemide—Diarrhoea—Methotrexate—esophageal cancer	6.8e-05	0.00413	CcSEcCtD
Torasemide—Dizziness—Methotrexate—esophageal cancer	6.57e-05	0.00399	CcSEcCtD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.54e-05	0.000848	CbGpPWpGaD
Torasemide—Vomiting—Methotrexate—esophageal cancer	6.32e-05	0.00384	CcSEcCtD
Torasemide—Rash—Methotrexate—esophageal cancer	6.27e-05	0.0038	CcSEcCtD
Torasemide—Dermatitis—Methotrexate—esophageal cancer	6.26e-05	0.0038	CcSEcCtD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.26e-05	0.000811	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC52A3—esophageal cancer	6.23e-05	0.000808	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—BLVRB—esophageal cancer	6.23e-05	0.000808	CbGpPWpGaD
Torasemide—Headache—Methotrexate—esophageal cancer	6.23e-05	0.00378	CcSEcCtD
Torasemide—PTGS1—Metabolism—ADH1B—esophageal cancer	6.12e-05	0.000793	CbGpPWpGaD
Torasemide—Nausea—Methotrexate—esophageal cancer	5.9e-05	0.00358	CcSEcCtD
Torasemide—PTGS1—Metabolism—TYMP—esophageal cancer	5.84e-05	0.000757	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.71e-05	0.00074	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP26A1—esophageal cancer	5.69e-05	0.000737	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.57e-05	0.000722	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	5.56e-05	0.000721	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—BLVRB—esophageal cancer	5.56e-05	0.000721	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALOX15—esophageal cancer	5.54e-05	0.000718	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CA1—esophageal cancer	5.3e-05	0.000687	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC10A2—esophageal cancer	5.3e-05	0.000687	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTO1—esophageal cancer	5.29e-05	0.000685	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—TPI1—esophageal cancer	5.29e-05	0.000685	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—BLVRB—esophageal cancer	5.07e-05	0.000657	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC52A3—esophageal cancer	5.07e-05	0.000657	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALDOB—esophageal cancer	5.07e-05	0.000657	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.97e-05	0.000644	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GAPDH—esophageal cancer	4.88e-05	0.000632	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CA2—esophageal cancer	4.85e-05	0.000628	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CRABP1—esophageal cancer	4.83e-05	0.000626	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.74e-05	0.000614	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CA1—esophageal cancer	4.73e-05	0.000613	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	4.73e-05	0.000613	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GNG7—esophageal cancer	4.6e-05	0.000596	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.53e-05	0.000587	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ADH7—esophageal cancer	4.5e-05	0.000584	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PLCE1—esophageal cancer	4.5e-05	0.000584	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.45e-05	0.000577	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CA2—esophageal cancer	4.33e-05	0.000561	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	4.31e-05	0.000559	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CA1—esophageal cancer	4.31e-05	0.000559	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALDH2—esophageal cancer	4.31e-05	0.000558	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.23e-05	0.000548	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTT1—esophageal cancer	4.1e-05	0.000531	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2A6—esophageal cancer	4.05e-05	0.000525	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.04e-05	0.000523	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ADH7—esophageal cancer	4.02e-05	0.000521	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PLCE1—esophageal cancer	4.02e-05	0.000521	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.97e-05	0.000515	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.95e-05	0.000512	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CA2—esophageal cancer	3.94e-05	0.000511	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.85e-05	0.0005	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ENO1—esophageal cancer	3.84e-05	0.000498	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PSME2—esophageal cancer	3.78e-05	0.00049	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PSME1—esophageal cancer	3.78e-05	0.00049	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TYMP—esophageal cancer	3.78e-05	0.000489	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.67e-05	0.000476	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.67e-05	0.000475	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ADH7—esophageal cancer	3.67e-05	0.000475	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.62e-05	0.00047	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.58e-05	0.000464	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ADH1B—esophageal cancer	3.53e-05	0.000457	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.41e-05	0.000442	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TPI1—esophageal cancer	3.41e-05	0.000442	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TYMP—esophageal cancer	3.37e-05	0.000437	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.3e-05	0.000428	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	3.28e-05	0.000425	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.27e-05	0.000424	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1B1—esophageal cancer	3.27e-05	0.000423	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ADH1B—esophageal cancer	3.21e-05	0.000417	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.19e-05	0.000414	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.15e-05	0.000408	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.12e-05	0.000405	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TYMP—esophageal cancer	3.07e-05	0.000398	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP19A1—esophageal cancer	3.07e-05	0.000398	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TPI1—esophageal cancer	3.05e-05	0.000395	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.05e-05	0.000395	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.99e-05	0.000387	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GNG7—esophageal cancer	2.97e-05	0.000385	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.92e-05	0.000379	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.91e-05	0.000377	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.81e-05	0.000364	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—HMOX1—esophageal cancer	2.8e-05	0.000363	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.79e-05	0.000361	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.78e-05	0.000361	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TPI1—esophageal cancer	2.78e-05	0.00036	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.78e-05	0.00036	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.75e-05	0.000356	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ABCB1—esophageal cancer	2.69e-05	0.000348	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.66e-05	0.000345	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GNG7—esophageal cancer	2.65e-05	0.000344	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.65e-05	0.000343	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.62e-05	0.000339	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.61e-05	0.000338	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.56e-05	0.000332	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.54e-05	0.000329	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.48e-05	0.000322	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ENO1—esophageal cancer	2.48e-05	0.000321	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.48e-05	0.000321	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PSME1—esophageal cancer	2.44e-05	0.000317	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PSME2—esophageal cancer	2.44e-05	0.000317	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GNG7—esophageal cancer	2.42e-05	0.000313	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.36e-05	0.000306	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.34e-05	0.000303	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.33e-05	0.000302	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.27e-05	0.000294	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.21e-05	0.000287	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ENO1—esophageal cancer	2.21e-05	0.000287	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PSME2—esophageal cancer	2.18e-05	0.000283	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PSME1—esophageal cancer	2.18e-05	0.000283	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.15e-05	0.000279	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.13e-05	0.000277	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.13e-05	0.000276	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.12e-05	0.000275	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.11e-05	0.000273	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.03e-05	0.000263	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ENO1—esophageal cancer	2.02e-05	0.000262	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.02e-05	0.000262	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PSME2—esophageal cancer	1.99e-05	0.000258	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PSME1—esophageal cancer	1.99e-05	0.000258	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.98e-05	0.000257	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.91e-05	0.000247	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.88e-05	0.000244	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.81e-05	0.000235	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CREBBP—esophageal cancer	1.8e-05	0.000233	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.78e-05	0.00023	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.77e-05	0.000229	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.74e-05	0.000225	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.74e-05	0.000225	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.72e-05	0.000222	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.62e-05	0.000209	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.61e-05	0.000209	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NOS3—esophageal cancer	1.61e-05	0.000209	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.58e-05	0.000205	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.55e-05	0.000201	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.47e-05	0.000191	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTGS2—esophageal cancer	1.47e-05	0.000191	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.44e-05	0.000187	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.41e-05	0.000183	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.31e-05	0.00017	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—EP300—esophageal cancer	1.22e-05	0.000159	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.17e-05	0.000152	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.16e-05	0.00015	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.07e-05	0.000139	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NOS3—esophageal cancer	1.04e-05	0.000135	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.04e-05	0.000134	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS2—esophageal cancer	9.51e-06	0.000123	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CREBBP—esophageal cancer	9.45e-06	0.000122	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NOS3—esophageal cancer	9.28e-06	0.00012	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CA—esophageal cancer	9.05e-06	0.000117	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS2—esophageal cancer	8.48e-06	0.00011	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NOS3—esophageal cancer	8.46e-06	0.00011	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—EP300—esophageal cancer	7.91e-06	0.000102	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS2—esophageal cancer	7.74e-06	0.0001	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—EP300—esophageal cancer	7.06e-06	9.15e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—EP300—esophageal cancer	6.43e-06	8.34e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CA—esophageal cancer	5.85e-06	7.58e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	5.22e-06	6.77e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.76e-06	6.17e-05	CbGpPWpGaD
